Skip to main content

A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.

Publication ,  Conference
Millstein, J; Budden, T; Anglesio, M; Talhouk, A; Beeghly-Fadiel, A; Berchuck, A; Chenevix-Trench, G; deFazio, A; Fasching, PA; Gayther, S ...
Published in: Journal of Clinical Oncology
May 20, 2018

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

5583 / 5583

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Millstein, J., Budden, T., Anglesio, M., Talhouk, A., Beeghly-Fadiel, A., Berchuck, A., … Ramus, S. J. (2018). A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer. In Journal of Clinical Oncology (Vol. 36, pp. 5583–5583). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.5583
Millstein, Joshua, Timothy Budden, Michael Anglesio, Aline Talhouk, Alicia Beeghly-Fadiel, Andrew Berchuck, Georgia Chenevix-Trench, et al. “A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.” In Journal of Clinical Oncology, 36:5583–5583. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5583.
Millstein J, Budden T, Anglesio M, Talhouk A, Beeghly-Fadiel A, Berchuck A, et al. A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5583–5583.
Millstein, Joshua, et al. “A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 5583–5583. Crossref, doi:10.1200/jco.2018.36.15_suppl.5583.
Millstein J, Budden T, Anglesio M, Talhouk A, Beeghly-Fadiel A, Berchuck A, Chenevix-Trench G, deFazio A, Fasching PA, Gayther S, García M, Goode EL, Henderson M, Konecny GE, Orsulic S, Huntsman D, Bowtell D, Doherty J, Pharoah P, Ramus SJ. A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5583–5583.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

5583 / 5583

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences